Jason Reiser, most recently Vitamin Shoppe’s EVP and COO, brings with him to Dollar General more than 30 years’ experience in retail management, private brand sourcing and regulatory affairs.
Teva’s generic will be available in 75- and 150-mg dosage strengths.
The Food and Drug Administration’s Drug Competition Action Plan begins with a public hearing on July 18 to assess the places where FDA regulations could be creating obstacles to generic access.
With the development of TREO, Gillette appears to be positioning itself to meet the needs of the ever-growing pool of American caregivers — which is expected to comprise 50 million people by 2020.
Camber’s generic will be available in 20-, 40-, and 80-mg dosage strengths and packaged in 3x10 blister cards.
Halperin will speak at the NACDS Political Involvement Reception, which takes place Aug. 19 — the first night of NACDS Total Store Expo, which will be held in San Diego through Aug. 22.
CTA projects U.S. unit sales of all wearable tech devices will reach 48 million units in 2017 (a 14% year-over-year increase) and earn $5.5 billion in revenue (a 3% increase).
According to the CDC, American adults are behind on routine annual vaccinations.
Approximately 73% of Americans over the age of 50 who experience issues with joint comfort have admitted to skipping an outing or activity because they are concerned about their discomfort.
Walgreens Boots Alliance and Theranos have tentatively reached accord on a $30 million agreement, according to a story published Wednesday in The Wall Street Journal. Walgreens had been seeking $140 million as part of a breach of contract suit in an attempt to recover the cost of its investment. According to reports, Theranos recently told investors it had about $54 million in cash left to settle suits, down from $187 million in January. (The Wall Street Journal)